Udenafil is a potent and selective phosphodiesterase type 5 (PDE5) inhibitor used for the treatment of erectile dysfunction (ED). Developed by Dong-A Pharmaceutical, udenafil is characterized by its relatively rapid onset of action.
The above information is displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.
| Other Names | Zydena, DA-8159 |
|---|---|
| IUPAC Name | 3-(1-methyl-7-oxo-3-propyl-6H-pyrazolo[4, 3-d]pyrimidin-5-yl)-N-[2-(1-methylpyrrolidin-2-yl)ethyl]-4-propoxybenzenesulfonamide |
| CAS | 268203-93-6 |
| Molecular Weight | 516.7 |
| Molecular Formula | C25H36N6O4S |
| SMILES | CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)NCCC4CCCN4C)OCCC)C |